Toxicity	toxicity	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
remission	remission	O	O	O	O
inducing	inducing	O	O	O	O
drugs	drugs	O	O	O	O
in	in	O	O	O	O
rheumatoid	rheumatoid	O	DISEASE	OTHERS	I
arthritis	arthritis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Association	association	O	O	O	O
with	with	O	O	O	O
HLA-B35	hla-b35	O	O	O	O
and	and	O	O	O	O
Cw4	cw4	O	O	O	O
antigens	antigens	O	O	O	O
.	.	O	O	O	O

Twenty-five	twenty-five	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
rheumatoid	rheumatoid	O	DISEASE	OTHERS	I
arthritis	arthritis	O	DISEASE	OTHERS	I
(	(	O	O	O	O
RA	ra	O	O	OTHERS	I
)	)	O	O	O	O
who	who	O	O	O	O
developed	developed	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
while	while	O	O	O	O
taking	taking	O	O	O	O
remission	remission	O	O	O	O
inducing	inducing	O	O	O	O
drugs	drugs	O	O	O	O
and	and	O	O	O	O
30	30	O	O	O	O
without	without	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
were	were	O	O	O	O
studied	studied	O	O	O	O
for	for	O	O	O	O
possible	possible	O	O	O	O
associations	associations	O	O	O	O
with	with	O	O	O	O
class	class	O	O	O	O
I	i	O	O	O	O
and	and	O	O	O	O
II	ii	O	O	O	O
HLA	hla	CHEMICALS	O	OTHERS	I
antigens	antigens	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
strong	strong	O	O	O	O
association	association	O	O	O	O
has	has	O	O	O	O
been	been	O	O	O	O
found	found	O	O	O	O
between	between	O	O	O	O
nephritis	nephritis	O	O	OTHERS	I
and	and	O	O	O	O
dermatitis	dermatitis	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
Tiopronin	tiopronin	O	O	OTHERS	I
(	(	O	O	O	O
a	a	O	O	O	O
D-Penicillamine	d-penicillamine	O	O	O	O
like	like	O	O	O	O
compound	compound	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
class	class	O	O	O	O
I	i	O	O	O	O
antigens	antigens	O	O	O	O
B35-Cw4	b35-cw4	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
between	between	O	O	O	O
dermatitis	dermatitis	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
gold	gold	O	O	OTHERS	I
thiosulphate	thiosulphate	O	O	OTHERS	I
and	and	O	O	O	O
B35	b35	O	O	O	O
.	.	O	O	O	O

Compared	compared	O	O	O	O
to	to	O	O	O	O
healthy	healthy	O	O	O	O
controls	controls	O	O	O	O
a	a	O	O	O	O
lower	lower	O	O	O	O
DR5	dr5	O	O	O	O
frequency	frequency	O	O	O	O
was	was	O	O	O	O
observed	observed	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
RA	ra	O	O	OTHERS	I
except	except	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
Tiopronin	tiopronin	O	O	OTHERS	I
related	related	O	O	O	O
nephritis	nephritis	O	O	OTHERS	I
group	group	O	O	O	O
.	.	O	O	O	O

